<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: organ transplant recipients</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Study reveals optimal treatment for most common infection after organ transplantation</title>
   	 <description> Waiting to treat the commonest viral infections in transplant recipients until they reach a certain threshold is better than prophylactically treating all recipients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).</description>
     <link>http://medicalxpress.com/news/2012-08-reveals-optimal-treatment-common-infection.html</link>
	 <category>Other</category>
	 <pubDate>Thu, 23 Aug 2012 17:10:01 EST</pubDate>
	 <guid isPermaLink="false">news264953486</guid>
	 
</item>
<item>
     <title>Factors tied to photoprotection ID'd for organ recipients</title>
   	 <description>(HealthDay) -- For organ transplant recipients, patients factors, including sex and skin type, and receipt of advice from health care providers, are both associated with sun protective behaviors, according to a study published online Aug. 9 in the British Journal of Dermatology.</description>
     <link>http://medicalxpress.com/news/2012-08-factors-tied-photoprotection-idd-recipients.html</link>
	 <category>Surgery</category>
	 <pubDate>Tue, 21 Aug 2012 15:40:01 EST</pubDate>
	 <guid isPermaLink="false">news264774264</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/factorstiedt.jpg" width="90" height="90" />
</item>
<item>
     <title>Use of stem cells, conditioning induces immune tolerance</title>
   	 <description>(HealthDay) -- A novel approach using a bioengineered mobilized cellular product enriched with hematopoietic stem cells (HSCs) and tolerogenic graft facilitating cells (FCs) in combination with nonmyeloablative conditioning is safe and practical for inducing immune tolerance after transplantation, according to a study published in the March 7 issue of Science Translational Medicine.</description>
     <link>http://medicalxpress.com/news/2012-03-stem-cells-conditioning-immune-tolerance.html</link>
	 <category>Immunology</category>
	 <pubDate>Thu, 08 Mar 2012 16:20:01 EST</pubDate>
	 <guid isPermaLink="false">news250442462</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/useofstemcel.jpg" width="90" height="90" />
</item>
<item>
     <title>New transplant method may allow kidney recipients to live life free of anti-rejection medication</title>
   	 <description>New ongoing research published today in the journal Science Translational Medicine suggests organ transplant recipients may not require anti-rejection medication in the future thanks to the power of stem cells, which may prove to be able to be manipulated in mismatched kidney donor and recipient pairs to allow for successful transplantation without immunosuppressive drugs. Northwestern Medicine&amp;#174; and University of Louisville researchers are partnering on a clinical trial to study the use of donor stem cell infusions that have been specially engineered to &quot;trick&quot; the recipients' immune system into thinking the donated organ is part of the patient's natural self, thus gradually eliminating or reducing the need for anti-rejection medication.</description>
     <link>http://medicalxpress.com/news/2012-03-transplant-method-kidney-recipients-life.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 07 Mar 2012 14:00:02 EST</pubDate>
	 <guid isPermaLink="false">news250347854</guid>
	 
</item>
<item>
     <title>Mayo Clinic makes kidney and pancreas transplant available to HIV-infected patients</title>
   	 <description>Mayo Clinic in Florida is now offering kidney and pancreas transplants to HIV positive patients with advanced kidney disease and diabetes. Evidence is now solid that HIV-positive patients have the same favorable outcome in terms of patient and allograft survival as non-HIV positive organ transplant recipients, says Mary Prendergast, M.D., a kidney specialist whose focus is the care of patients who receive kidney and pancreas transplants.</description>
     <link>http://medicalxpress.com/news/2011-12-mayo-clinic-kidney-pancreas-transplant.html</link>
	 <category>Other</category>
	 <pubDate>Tue, 06 Dec 2011 13:02:52 EST</pubDate>
	 <guid isPermaLink="false">news242398957</guid>
	 
</item>
<item>
     <title>NIH scientists outline steps toward Epstein-Barr virus vaccine</title>
   	 <description>Epstein-Barr virus (EBV) infects nine out of ten people worldwide at some point during their lifetimes. Infections in early childhood often cause no disease symptoms, but people infected during adolescence or young adulthood may develop infectious mononucleosis, a disease characterized by swollen lymph nodes, fever and severe fatigue. EBV also is associated with several kinds of cancer, including Hodgkin lymphoma and stomach and nasal cancers. Organ transplant recipients and people infected with HIV (who become infected with or who already are infected with EBV) also may develop EBV-associated cancers. There is no vaccine to prevent EBV infection and no way for doctors to predict whether an EBV-infected person will develop virus-associated cancer.</description>
     <link>http://medicalxpress.com/news/2011-11-nih-scientists-outline-epstein-barr-virus.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 02 Nov 2011 15:43:22 EST</pubDate>
	 <guid isPermaLink="false">news239467388</guid>
	 
</item>
<item>
     <title>Recipients of organ transplants at increased risk for broad range of cancers</title>
   	 <description>Patients who have received a solid organ transplant, such as kidney, liver, heart or lung, have an overall cancer risk that is double that of the general population, with an increased risk for many different types of malignancies, according to a study in the November 2 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2011-11-recipients-transplants-broad-range-cancers.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 01 Nov 2011 16:26:55 EST</pubDate>
	 <guid isPermaLink="false">news239383608</guid>
	 
</item>
<item>
     <title>HPV infection highly prevalent among organ transplant recipients</title>
   	 <description>A new study published in the American Journal of Transplantation reveals an association between the human papillomavirus (betaPV) infection and cutaneous squamous cell carcinoma (SCC) in organ transplant recipients.</description>
     <link>http://medicalxpress.com/news/2011-07-hpv-infection-highly-prevalent-transplant.html</link>
	 <category>Other</category>
	 <pubDate>Tue, 12 Jul 2011 10:38:18 EST</pubDate>
	 <guid isPermaLink="false">news229685882</guid>
	 
</item>


</channel>
</rss>
